CENPs have been shown to be potential targets for cancer therapy, with CENP-E being proposed as a potential target even before its relationship with ovarian cancer was revealed, leading to the development of chemical inhibitors for CENP-E [24]. This evidence concerns the gene CENPE and ovarian cancer.